Effects and Feasibility of Photobiomodulation at 830nm Nanometers in the Treatment of Diabetic Ulcers

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 136 participants.

Also called NCT07043868

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose health services research
Phase
Not applicable
Enrolled
  • 136 participants (planned count) (from the registry)
Sponsor
Federal University of Piaui (from the registry)
Registry
  • NCT NCT07043868
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07043868. Randomized; triple masking; primary purpose health services research. Start 2026-01-10 (anticipated); primary completion 2027-01-10 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Effects and Feasibility of Photobiomodulation at 830nm Nanometers in the Treatment of Diabetic Ulcers
Condition
Diabete Type 2
Condition
Diabetic Foot Ulcer
Condition
Photobiomodulation
Condition
Low Level Laser Therapy
Intervention (Device)
Low Level Laser Therapy
Lead sponsor
Federal University of Piaui (class: other)

Record details

Record id
cardio:ct-nct07043868
Content hash
1451814ad9760ed63ad7eee39e51858f7e81cc5c687c32ac461a03c285f14642